Weight Loss

Health care professionals who experienced recent weight loss had a significantly higher risk for a cancer diagnosis during the subsequent 12 months, results of a prospective cohort analysis revealed.

Adults who lose any amount of weight 1 year after being diagnosed with type 2 diabetes are more likely to achieve diabetes remission than those who gain weight, according to study data published in PLOS Medicine.

The risk for all-cause mortality decreases among patients with knee or hip osteoarthritis who achieve slow-to-moderate, but not fast, weight loss via anti-obesity medications, according to data published in Arthritis & Rheumatology.

Preliminary results from an ongoing FDA investigation found no evidence that weight-loss drugs cause suicidal ideations and aspirations, although the agency said it cannot rule out a risk entirely.

An FDA investigation of popular weight-loss drugs has generated a storm of media attention and prompted patient questions.

Adults who initiated once-weekly semaglutide after not responding to bariatric surgery lost a similar amount of weight as those without a history of bariatric surgery, according to study findings published in Obesity.

Women who underwent bariatric surgery gained less weight during pregnancy compared with matched controls, and weight gain was lower in those who conceived shortly after surgery, according to data in JAMA Network Open.

The AMA has adopted a policy in support of insurance coverage parity for evidence-based weight-loss medications “without exclusions or additional carve-outs,” the organization recently announced.

Continued treatment with the GIP/GLP-1 dual agonist tirzepatide is necessary to maintain weight loss for adults with obesity, according to findings from the SURMOUNT-4 trial published in JAMA.

As the first point of contact for many patients, it is important for primary care physicians to have strategies that will help treat and manage overweight and obesity, according to experts.